Also trades as: SABSW (NASDAQ) · $vol 0M
SABS NASDAQ
SAB Biotherapeutics, Inc.
1W: -9.4%
1M: -20.5%
3M: -24.0%
YTD: -20.9%
1Y: +50.5%
3Y: -36.3%
5Y: -97.0%
$2.98
-0.08 (-2.61%)
Weekly Expected Move ±4.6%
$3
$3
$3
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
ESG Scores — SABS
Company vs Sector Average
Historical ESG Trend
View All ESG Filings (20)
| Date | Form | Environmental | Social | Governance | ESG Score | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | 10-Q | 64.2 | 73.6 | 71.5 | 69.8 | SEC ↗ |
| 2026-03-31 | 10-Q | 65.6 | 70.2 | 74.3 | 70.0 | SEC ↗ |
| 2025-12-31 | 10-K | 60.1 | 66.2 | 60.8 | 62.4 | SEC ↗ |
| 2025-09-30 | 10-Q | 67.7 | 72.4 | 74.8 | 71.6 | SEC ↗ |
| 2025-06-30 | 10-Q | 65.4 | 71.3 | 73.8 | 70.2 | SEC ↗ |
| 2025-03-31 | 10-Q | 62.8 | 72.2 | 74.9 | 70.0 | SEC ↗ |
| 2024-12-31 | 10-K | 57.8 | 66.1 | 59.4 | 61.1 | SEC ↗ |
| 2024-09-30 | 10-Q | 62.2 | 70.4 | 71.9 | 68.2 | SEC ↗ |
| 2024-06-30 | 10-Q | 62.2 | 69.9 | 71.6 | 67.9 | SEC ↗ |
| 2024-03-31 | 10-Q | 58.2 | 70.0 | 71.3 | 66.5 | SEC ↗ |
| 2023-12-31 | 10-K | 57.2 | 66.3 | 59.3 | 60.9 | SEC ↗ |
| 2023-09-30 | 10-Q | 65.5 | 67.2 | 72.5 | 68.4 | SEC ↗ |
| 2023-06-30 | 10-Q | 66.7 | 65.0 | 72.2 | 68.0 | SEC ↗ |
| 2023-03-31 | 10-Q | 65.6 | 65.9 | 72.7 | 68.1 | SEC ↗ |
| 2022-12-31 | 10-K | 57.5 | 64.8 | 61.3 | 61.2 | SEC ↗ |
| 2022-09-30 | 10-Q | 57.0 | 66.2 | 72.6 | 65.3 | SEC ↗ |
| 2022-06-30 | 10-Q | 56.6 | 67.6 | 73.0 | 65.7 | SEC ↗ |
| 2021-09-30 | 10-Q | 63.5 | 79.6 | 69.6 | 70.9 | SEC ↗ |
| 2021-06-30 | 10-Q | 67.9 | 76.4 | 66.0 | 70.1 | SEC ↗ |
| 2020-12-31 | 10-K | 86.8 | 69.7 | 63.4 | 73.3 | SEC ↗ |